Shopping Cart


ASCO San Francisco, May 31-June 4, 2013

May 13, 2013

"Detection and Genomic Interrogation of Circulating Tumor Cells (CTCs) and Circulating Tumor Stem Cells (CTSCs) from Men with Metastatic Castration-resistant Prostate Cancer (mCRPC)". Terence Friedlander, Pamela Paris and colleagues from UCSF, working with Vitatex and SUNY Stonybrook, employed the Vitatex platform to capture CTCs and CSTCs to compare yields between CAM-based isolation and the CellSearch method, to determine the utility of prostate-specific membrane antigen (PSMA) as a mCRPC CTC biomarker, to identify CTSCs and CTC clusters, and to confirm feasibility of epigenomic analysis of CAM-isolated CTCs.

Read more →

AACR Washington DC, April 6-10, 2013

April 01, 2013

Vitatex and Stonybrook Medicine will present Late-Breaking Research poster abstract #9095 "Circulating Tumor Cells with the Invasive Phenotype Predict Progression-free Survival and Overall Survival in Preoperative Patients Diagnosed with Advanced Epithelial Ovarian Cancer" which describes robust prognosis of preoperative patients for advanced epithelial ovarian cancer that could help tailor appropriate therapy.

Read more →

ASCO GI San Francisco, January 24-26, 2013

January 28, 2013

Vitatex CAM technology featured in two papers presented at this year's ASCO GI conference in San Francisco. Researchers from John Hopkins/Centro Integral Oncológico Clara Campal and Memorial Sloan-Kettering Cancer Center present. 

Read more →

Vitatex Receives Award for Best Overall Presentation at Molecular Triconference Partnering Forum, San Francisco, February 12, 2013

January 14, 2013

Casey Eitner, Vitatex’s SVP of Business Development, presented a talk titled “Cell Adhesion Matrix-Based Isolation of Invasive Circulating Tumor Cells – iCTCs". Dr.Wen-Tien Chen, Vitatex’s Scientific Founder and President, presented at the Circulating Tumor Cell program of the Triconference with a talk entitled “Application of iCTC Detection and Culture in Personalized Cancer Management”.

Read more →

Vitatex is awarded its year-4 Small Business Innovative Research (SBIR) grant

September 01, 2012

Vitatex is awarded its year-4 Small Business Innovative Research (SBIR) grant from the NCI (grant #R44CA140047; title: Cancer progenitor cell markers). The goals of this proposal are to discover cancer progenitor cell markers for improved detection of circulating tumor cells in patients with epithelial ovarian cancer, and to evaluate the potential role of CTCs in ovarian tumor peritoneal metastasis.

Read more →